Crisis Center

A batch failure or batch hold

A held batch is simultaneously a quality investigation, a working-capital problem and a supply conversation. Handling only the first of those is how the other two escalate.

The one thing

Establish product impact and supply consequence in parallel, because the timelines for each are different.

First actionsConsiderations, not a mandated sequence — assess against your own procedures.

Roughly the first working day

  • Quarantine and confirm status in the systemEnsure the batch cannot move, and that the hold is visible to everyone who might otherwise plan around it.
  • Establish whether this is isolatedOther batches sharing the equipment, material lot, personnel or period, including batches already released.
  • Inform supply planning earlyNot to accelerate the investigation, but so the supply consequence is managed on its own timeline rather than discovered late.
  • Decide who owns the disposition decisionWhere certification is in prospect, the QP's requirements for that decision should be understood at the outset.
Evidence

What must not be lost while people react

  • Complete batch record with in-process results and any deviations raised.
  • Equipment, utility and environmental data for the manufacturing period.
  • Material lot traceability upstream and downstream.
  • Analytical data in original form.
Questions

What shapes the investigation

  1. 01What is the confirmed failure mode, and what evidence supports it?
  2. 02Which other batches could share it, and what is their disposition status?
  3. 03If product has reached the market, what is the assessment of patient risk?
  4. 04Is rework or reprocessing permissible for this product under its marketing authorisation?
  5. 05What supply interruption follows, and over what period?
Regulatory considerationsWhether an obligation is engaged depends on your product, market and facts.

Things to consider, not conclusions to adopt

  • Reprocessing and rework are constrained by the marketing authorisation; what is technically possible may not be permitted.
  • Where released product may be affected, complaint, quality defect and recall processes may be engaged — assess against your own procedures and take advice.
  • Certification of a batch affected by an unresolved deviation is addressed in Annex 16 and requires documented rationale.
  • Where supply interruption is likely, consider whether shortage notification obligations apply in your markets.
Under pressure

What sites commonly get wrong

  • Treating it purely as a quality event until the supply consequence becomes urgent.
  • Assessing only the failed batch and not the population that shares its cause.
  • Pressure to release on a narrow technical argument that will not survive review.
  • Deciding on rework before confirming it is permitted for the product.
The full sequenceSkipping verification is how an event returns as a repeat finding.

Ten steps, in this order

  1. 01

    Contain

    Stop the situation getting worse. Quarantine affected material, halt the process step if continuing would compound the problem, and secure the area or system involved.

  2. 02

    Assess

    Establish what is known versus assumed. What happened, when, to what, and who observed it. Resist the pull to conclude a cause in the first hour.

  3. 03

    Escalate

    Notify according to your own procedure. Getting the right people informed early costs little; discovering later that QA or the QP was not told is itself a finding.

  4. 04

    Investigate

    Establish the cause with evidence rather than plausibility. Depth should be proportionate to risk, but the standard for a confirmed cause does not move.

  5. 05

    Document

    Record contemporaneously as you go. Reconstructing a record afterwards converts a quality problem into a data integrity problem, which is a different order of seriousness.

  6. 06

    Determine impact

    Assess product impact beyond the batch in front of you — other batches sharing equipment, materials, personnel or time window, and material already released.

  7. 07

    Correct

    Fix the immediate instance, and separately address the cause. Conflating correction with corrective action is the most common weakness in a response.

  8. 08

    Prevent recurrence

    Address why the process permitted the event. Where the design invites the error, training a person not to make it is a delay rather than a correction.

  9. 09

    Verify effectiveness

    Check against a criterion defined before implementation. This is the step most often skipped, and the one that decides whether the event returns as a repeat finding.

  10. 10

    Close and monitor

    Close with evidence attached, and keep the indicator under review long enough to know the fix held rather than merely completed.

Limits

This is quality guidance, not legal advice

This is practical quality guidance, not legal or regulatory advice. Whether a specific event triggers a particular regulatory obligation depends on the product, the market, the marketing authorisation and the facts. Assess against your own procedures, and take qualified advice where the situation may involve notification, recall or a deliberate act.

Need help now?

A date you did not choose

If there is a response deadline or an investigation that has to hold up under scrutiny, a short call is the fastest route to a view on what to do first.